Locally Advanced Malignant Neoplasm Recruiting Phase 3 Trials for Fulvestrant (DB00947)

IndicationStatusPhase
DBCOND0047902 (Locally Advanced Malignant Neoplasm)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02404051Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast CancerTreatment